Grantham, Mayo, Van Otterloo & Co (GMO)’s Cross Country Healthcare CCRN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,900	Closed	-$278K	–	592
2023 Q2	$278K	Hold	9,900	–	–	﹤0.01%	613
2023 Q1	$221K	Buy	+9,900	New	+$259K	﹤0.01%	648
2022 Q2	–	Sell	-12,100	Closed	-$262K	–	756
2022 Q1	$262K	Sell	12,100 -55,000	-82%	-$1.19M	﹤0.01%	659
2021 Q4	$1.86M	Buy	67,100 +10,700	+19%	+$259K	0.01%	474
2021 Q3	$1.2M	Buy	56,400 +40,800	+262%	+$765K	0.01%	511
2021 Q2	$258K	Buy	+15,600	New	+$238K	﹤0.01%	680

Other funds holding CCRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CCRN Position: Q3 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Cross Country Healthcare (CCRN) in Q3 2023, closing a stake of 9,900 shares — an estimated $278K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CCRN in Q2 2021 and held it in 6 quarters. The position peaked at $1.86M in Q4 2021. 189 funds tracked by Wall St. Rank hold CCRN as of Q3 2023.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Cross Country Healthcare position as of Q3 2023 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 9,900 Cross Country Healthcare shares in Q3 2023, an estimated $278K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cross Country Healthcare in Q2 2021 and held it in 6 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Cross Country Healthcare position peaked at $1.86M in Q4 2021.
189 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2023, filed 13 Nov 2023.